About Admin

David experienced an adverse event to the the fluoroquinolone Levaquin in 2007 at age 46. Prior to, he was a healthy law enforcement official. Now, disabled with drug induced mitochondrial disease/dysfunction, he is an FQ patient safety advocate, citizen scientist, FQ researcher, author, and commentator. He has contributed to case studies and published academic papers on the FQ’s in the BMJ, European Journal of Medicine, The Journal of Community and Supportive Oncology, Oxford Academic Clinical infectious Diseases, and contributed data to many more outlets.

Mitochondrial Retrograde Signaling in FQAD, A Disease Theory

Based on many years of anecdotal evidence by citizen scientists, and the results of some recent research findings, this paper proposes a theory that, if proven true, would suggest a novel mechanism behind FQAD in an otherwise healthy population in the absence of genetic predispositions.

Incredible Fluoroquinolone Diagnosis from a Mayo Researcher

David tells how an altruistic Mayo genetics researcher has unlocked yet another piece to the Fluoroquinolone puzzle. He further elaborates on how Mayo uncovered what other doctors had missed, and describes the state-of-the-art equipment needed to finally get to the bottom of Fluoroquinolone Toxicity.

Go to Top